Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 99420 · Class II · LifeShare Blood Centers
Key facts
| Event ID | 99420 |
|---|---|
| Recall numbers | B-0183-2026 |
| Recalling firm | LifeShare Blood Centers |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed. |
| Initiation date | Apr 15, 2026 |
| Report date | Aug 19, 2026 |
| Termination date | Aug 12, 2026 |
| City | Monroe |
| State | LA |
| Country | United States |
| FEI number | 2377717 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: